Skip to content

Mesh Fixation in Lichtenstein Hernioplasty

A Randomized Multi-center Study of Tissue Glue Fixation of Optilene™ Mesh With Histoacryl™ or Self-gripping Parietex ProGrip™ Compared to Conventional Non-absorbable Suture Fixation of Ultrapro™ Mesh

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01592942
Enrollment
650
Registered
2012-05-07
Start date
2012-08-31
Completion date
2021-12-31
Last updated
2020-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

inguinal hernia, mesh fixation, glue, Lichtenstein

Brief summary

This is a prospective, randomized multi-centre study to find out most safe, feasible, painless and cost-effective mesh fixation method in inguinal hernia operation. Three mesh fixation techniques are compared to find out best technique in local anaesthesia Lichtenstein operation. Our hypothesis is that glue fixation is safe, simple and cheap method compared to conventional Lichtenstein technique.

Detailed description

Some 650 patients with inguinal hernia are operated using Lichtenstein operation in local anaesthesia. Mesh fixation is performed using 3 methods: Optilene™ mesh + cyanoacrylate glue (n=200), self-fixing Parietex Progrip™ mesh (n=200) and non-absorbable sutures with Ultrapro™ mesh (n=200). Operative time and pain scores, immediate postoperative outcome, quality-of-life and total costs are followed 1, 7, 30 days and 1 and 5 years postoperatively.

Interventions

cyanoacrylate glue fixation of mesh 1 ml

DEVICEProgrip

self-gripping mesh

DEVICEsutures (prolene 3-0)

non-absorbable suture fixation 3-0

Sponsors

Helsinki University Central Hospital
CollaboratorOTHER
Paijat-Hame Hospital District
CollaboratorOTHER
North Karelia Central Hospital
CollaboratorOTHER
East Savo Hospital District
CollaboratorOTHER
Kuopio University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* primary or recurrent inguinal hernia * unilateral or bilateral

Exclusion criteria

* femoral hernia * massive scrotal hernia * allergy to polypropylene * patient's refusal

Design outcomes

Primary

MeasureTime frameDescription
pain5 yearspain scores (VAS 0-10) preoperatively and after surgery

Secondary

MeasureTime frameDescription
costs1 yearoperative cost-effectiveness

Countries

Finland

Contacts

Primary ContactHannu EK Paajanen, MD, PhD
hannu.paajanen@kuh.fi+358-40-3589905
Backup ContactKirsi Rönkä, MD
kirsi.ronka@kuh.fi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026